We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+9.21%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.6B
AUM Growth
+$475M
(+9.3%)
Cap. Flow
+$41M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
897
New
106
Increased
245
Reduced
364
Closed
101
Avg Time Held
1.9
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IHS Markit Ltd. Common Shares
INFO
|
+$37.5M |
| 2 |
Charles Schwab
SCHW
|
+$25.3M |
| 3 |
Abbott
ABT
|
+$17.5M |
| 4 |
Blackstone
BX
|
+$14.7M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAV
B/E Aerospace Inc
BEAV
|
+$46.3M |
| 2 |
Acuity Brands
AYI
|
+$34.4M |
| 3 |
SBA Communications
SBAC
|
+$30.9M |
| 4 |
Idexx Laboratories
IDXX
|
+$18M |
| 5 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$17.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.99% |
| 2 | Financials | 15.82% |
| 3 | Technology | 14.83% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Colgate-Palmolive
CL
$73.9B
| $1.32M | 0.02% |
18,051
+438
| +2% | +$30.7K |
2013 Q2
15 quarters
|
|
277
Thermo Fisher Scientific
TMO
$258B
| $1.32M | 0.02% |
8,572
-719
| -8% | -$110K |
2015 Q2
7 quarters
|
|
278
Vanguard Dividend Appreciation ETF
VIG
$113B
| $1.31M | 0.02% |
14,614
+122
| +0.8% | +$10.8K |
2013 Q2
15 quarters
|
|
279
Forward Air
FWRD
$535M
| $1.31M | 0.02% |
27,451
+1,512
| +6% | +$73.3K |
2015 Q3
6 quarters
|
|
280
Globus Medical
GMED
$10.6B
| $1.3M | 0.02% |
44,044
+2,065
| +5% | +$56.4K |
2016 Q3
2 quarters
|
|
281
DELISTED
PartnerRe Ltd. 7.25% Series H Cumulative Redeemable Preferred Shares, $1.00 par value
PRE.PRH
| $1.3M | 0.02% |
45,671
+7,129
| +18% | +$200K |
2016 Q3
2 quarters
|
|
282
iShares Russell 1000 Value ETF
IWD
$83.7B
| $1.3M | 0.02% |
11,337
+1,961
| +21% | +$225K |
2013 Q2
15 quarters
|
|
283
T. Rowe Price
TROW
$21.6B
| $1.29M | 0.02% |
19,002
-1,962
| -9% | -$139K |
2013 Q2
15 quarters
|
|
|
ELLI
284
DELISTED
Ellie Mae Inc
ELLI
| $1.26M | 0.02% |
12,556
-994
| -7% | -$91.3K |
2015 Q3
6 quarters
|
|
|
NUVA
285
DELISTED
NuVasive, Inc.
NUVA
| $1.26M | 0.02% |
16,814
+860
| +5% | +$62.4K |
2015 Q3
6 quarters
|
|
286
Dycom Industries
DY
$7.77B
| $1.24M | 0.02% |
13,373
+4,014
| +43% | +$341K |
2016 Q2
3 quarters
|
|
287
Banco Santander
SAN
$195B
| $1.23M | 0.02% |
+211,935
| New | +$1.14M |
2017 Q1
0 quarters
|
|
288
Core Laboratories
CLB
$449M
| $1.22M | 0.02% |
10,580
-150
| -1% | -$17.4K |
2013 Q2
15 quarters
|
|
289
Eaton
ETN
$156B
| $1.2M | 0.02% |
16,232
+179
| +1% | +$12.7K |
2013 Q2
15 quarters
|
|
290
iShares Russell 1000 ETF
IWB
$49.2B
| $1.2M | 0.02% |
9,146
-555
| -6% | -$71.9K |
2013 Q2
15 quarters
|
|
291
Franklin Premier Income Trust
PPT
$313M
| $1.2M | 0.02% |
+227,430
| New | +$1.19M |
2017 Q1
0 quarters
|
|
|
HSKA
292
DELISTED
Heska Corp
HSKA
| $1.19M | 0.02% |
+11,346
| New | +$971K |
2017 Q1
0 quarters
|
|
|
DCM
293
DELISTED
NTT DOCOMO, Inc.
DCM
| $1.18M | 0.02% |
50,598
+2,845
| +6% | +$67.7K |
2016 Q2
3 quarters
|
|
294
DELISTED
Accelerate Diagnostics
AXDX
| $1.18M | 0.02% |
4,866
+211
| +5% | +$48.2K |
2013 Q4
13 quarters
|
|
295
Waste Management
WM
$89.6B
| $1.17M | 0.02% |
16,102
-1,300
| -7% | -$92.8K |
2013 Q2
15 quarters
|
|
296
DELISTED
Ansys
ANSS
| $1.17M | 0.02% |
10,978
-685
| -6% | -$68.6K |
2014 Q1
12 quarters
|
|
297
Trex
TREX
$4.71B
| $1.17M | 0.02% |
67,412
+3,856
| +6% | +$66.5K |
2013 Q2
15 quarters
|
|
298
Diamondback Energy
FANG
$54.8B
| $1.15M | 0.02% |
11,100
+375
| +3% | +$38.7K |
2014 Q4
9 quarters
|
|
299
NextEra Energy
NEE
$165B
| $1.14M | 0.02% |
35,632
-4,380
| -11% | -$138K |
2013 Q2
15 quarters
|
|
300
Five Below
FIVE
$12.3B
| $1.14M | 0.02% |
26,205
-13,822
| -35% | -$549K |
2015 Q4
5 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Geneva Advisors held 897 positions worth $5.6B, up 9.3% from $5.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geneva Advisors's Q1 2017 filing shows 106 new, 245 increased, 364 reduced and 101 closed positions. Its largest new stake was IHS Markit Ltd. Common Shares: 946,941 shares worth $39.7M. The largest sale was B/E Aerospace Inc, an estimated $46.3M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Financials and Technology.
- Geneva Advisors's largest Q1 2017 buy was IHS Markit Ltd. Common Shares: 946,941 shares worth $39.7M.
- Geneva Advisors added most to Abbott in Q1 2017, an estimated $17.5M increase.
- Geneva Advisors's biggest Q1 2017 reduction was B/E Aerospace Inc, cutting an estimated $46.3M.
- Geneva Advisors fully exited NXP Semiconductors in Q1 2017, selling an estimated $5.02M.
- Geneva Advisors's ten largest holdings make up 26% of its $5.6B portfolio in Q1 2017.
- Geneva Advisors opened 106 new positions and closed 101 in Q1 2017.
- Geneva Advisors's portfolio value rose 9.3% quarter-over-quarter to $5.6B.
Based on Geneva Advisors's 13F filing for Q1 2017, filed 1 May 2017.